(FC) Bioquímica y Genética
Departamento académico
Universidade de Lisboa
Lisboa, PortugalPublicaciones en colaboración con investigadores/as de Universidade de Lisboa (17)
2024
-
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
JHEP Reports, Vol. 6, Núm. 1
2023
-
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
JHEP Reports, Vol. 5, Núm. 5
-
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma
Molecular cancer therapeutics, Vol. 22, Núm. 3, pp. 343-356
-
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480
-
miR-21-5p promotes NASH-related hepatocarcinogenesis
Liver International, Vol. 43, Núm. 10, pp. 2256-2274
2022
-
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism
Nature medicine, Vol. 28, Núm. 4, pp. 752-765
-
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models
Journal of Hepatology, Vol. 77, Núm. 1, pp. 177-190
2021
-
Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD
Frontiers in Medicine, Vol. 8
-
Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity
Cell Death and Disease, Vol. 12, Núm. 6
-
Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancer (British Journal of Cancer, (2020), 123, 7, (1047-1059), 10.1038/s41416-020-0987-3)
British Journal of Cancer
-
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
Gut, Vol. 70, Núm. 12, pp. 2359-2372
2020
-
A novel serum metabolomic profile for the differential diagnosis of distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
Cancers, Vol. 12, Núm. 6
-
Current and novel therapeutic opportunities for systemic therapy in biliary cancer
British Journal of Cancer, Vol. 123, Núm. 7, pp. 1047-1059
-
Extracellular vesicles in non-alcoholic fatty liver disease: Key players in disease pathogenesis and promising biomarker tools
NAFLD and NASH: Biomarkers in Detection, Diagnosis and Monitoring (Springer International Publishing), pp. 157-180
2019
-
Diagnostic and prognostic biomarkers in cholangiocarcinoma
Liver International, Vol. 39, Núm. S1, pp. 108-122
2018
-
MiRNA-21 ablation protects against liver injury and necroptosis in cholestasis
Cell Death and Differentiation, Vol. 25, Núm. 5, pp. 857-872
2012
-
PLGA-based nanoparticles: An overview of biomedical applications
Journal of Controlled Release, Vol. 161, Núm. 2, pp. 505-522